Barclays Initiates Coverage on Teladoc Health (NYSE:TDOC)

Barclays initiated coverage on shares of Teladoc Health (NYSE:TDOC) in a report released on Tuesday, Marketbeat.com reports. The brokerage set an “equal weight” rating and a $8.50 price target on the health services provider’s stock. Barclays‘s price target points to a potential upside of 10.56% from the stock’s current price.

Several other equities research analysts also recently weighed in on the stock. BMO Capital Markets began coverage on shares of Teladoc Health in a research note on Thursday, November 13th. They issued a “market perform” rating and a $8.00 target price on the stock. Bank of America reduced their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 25th. Evercore ISI decreased their price objective on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research note on Thursday, October 30th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 1st. Finally, Citigroup increased their price target on Teladoc Health from $9.50 to $10.50 and gave the stock a “neutral” rating in a report on Tuesday, October 21st. Five equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and a consensus price target of $9.60.

Teladoc Health Trading Down 0.2%

Shares of TDOC stock opened at $7.69 on Tuesday. The company has a market cap of $1.36 billion, a PE ratio of -6.01 and a beta of 2.04. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The stock’s 50 day simple moving average is $7.99 and its two-hundred day simple moving average is $7.78. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The firm had revenue of $626.44 million during the quarter, compared to analysts’ expectations of $625.66 million. During the same quarter in the previous year, the business earned ($0.19) EPS. The company’s quarterly revenue was down 2.2% on a year-over-year basis. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Research analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Activity at Teladoc Health

In other news, insider Adam C. Vandervoort sold 5,720 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $7.49, for a total value of $42,842.80. Following the completion of the sale, the insider owned 80,732 shares in the company, valued at approximately $604,682.68. The trade was a 6.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Carlos Nueno sold 3,897 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total transaction of $29,188.53. Following the completion of the sale, the insider directly owned 27,175 shares of the company’s stock, valued at $203,540.75. The trade was a 12.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 16,150 shares of company stock worth $120,921 over the last three months. 0.58% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently bought and sold shares of TDOC. IFP Advisors Inc boosted its position in shares of Teladoc Health by 412.1% in the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after purchasing an additional 3,210 shares in the last quarter. CIBC Bancorp USA Inc. acquired a new position in Teladoc Health during the 3rd quarter valued at about $145,000. CANADA LIFE ASSURANCE Co raised its stake in Teladoc Health by 8.0% in the third quarter. CANADA LIFE ASSURANCE Co now owns 60,231 shares of the health services provider’s stock valued at $494,000 after buying an additional 4,458 shares during the last quarter. Verition Fund Management LLC boosted its holdings in Teladoc Health by 152.0% in the third quarter. Verition Fund Management LLC now owns 218,572 shares of the health services provider’s stock worth $1,690,000 after acquiring an additional 131,833 shares in the last quarter. Finally, Polymer Capital Management US LLC purchased a new stake in shares of Teladoc Health during the third quarter worth about $131,000. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.